Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products
- PMID: 15944249
- DOI: 10.4049/jimmunol.174.12.7506
Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products
Abstract
High mobility group box 1 (HMGB1) is an abundant and conserved nuclear protein that is released by necrotic cells and acts in the extracellular environment as a primary proinflammatory signal. In this study we show that human dendritic cells, which are specialized in Ag presentation to T cells, actively release their own HMGB1 into the extracellular milieu upon activation. This secreted HMGB1 is necessary for the up-regulation of CD80, CD83, and CD86 surface markers of human dendritic cells and for IL-12 production. The HMGB1 secreted by dendritic cells is also required for the clonal expansion, survival, and functional polarization of naive T cells. Using neutralizing Abs and receptor for advanced glycation end product-deficient (RAGE(-/-)) cells, we demonstrate that RAGE is required for the effect of HMGB1 on dendritic cells. HMGB1/RAGE interaction results in downstream activation of MAPKs and NF-kappaB. The use of an ancient signal of necrosis, HMGB1, by dendritic cells to sustain their own maturation and for activation of T lymphocytes represents a profitable evolutionary mechanism.
Similar articles
-
The effect of high mobility group box-1 protein on splenic dendritic cell maturation in rats.J Interferon Cytokine Res. 2009 Oct;29(10):677-86. doi: 10.1089/jir.2008.0104. J Interferon Cytokine Res. 2009. PMID: 19642897
-
Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein.J Biol Chem. 2004 Feb 27;279(9):7370-7. doi: 10.1074/jbc.M306793200. Epub 2003 Dec 4. J Biol Chem. 2004. PMID: 14660645
-
Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes.J Immunol. 2008 Feb 15;180(4):2270-5. doi: 10.4049/jimmunol.180.4.2270. J Immunol. 2008. PMID: 18250435
-
Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.Anticancer Res. 2017 Jan;37(1):1-7. doi: 10.21873/anticanres.11282. Anticancer Res. 2017. PMID: 28011467 Review.
-
An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies.Pharmacol Ther. 2014 Mar;141(3):347-57. doi: 10.1016/j.pharmthera.2013.11.001. Epub 2013 Nov 9. Pharmacol Ther. 2014. PMID: 24220159 Review.
Cited by
-
Alpha cell receptor for advanced glycation end products associate with glucagon expression in type 1 diabetes.Sci Rep. 2023 Aug 9;13(1):12948. doi: 10.1038/s41598-023-39243-x. Sci Rep. 2023. PMID: 37558746 Free PMC article.
-
Fiber Optic Localized Surface Plasmon Resonance Sensor Based on Carboxymethylated Dextran Modified Gold Nanoparticles Surface for High Mobility Group Box 1 (HMGB1) Analysis.Biosensors (Basel). 2023 May 6;13(5):522. doi: 10.3390/bios13050522. Biosensors (Basel). 2023. PMID: 37232883 Free PMC article.
-
Do advanced glycation end products contribute to food allergy?Front Allergy. 2023 Apr 4;4:1148181. doi: 10.3389/falgy.2023.1148181. eCollection 2023. Front Allergy. 2023. PMID: 37081999 Free PMC article. Review.
-
HMGB1, angel or devil, in ischemic stroke.Brain Behav. 2023 May;13(5):e2987. doi: 10.1002/brb3.2987. Epub 2023 Apr 16. Brain Behav. 2023. PMID: 37062906 Free PMC article. Review.
-
Activation of immune signals during organ transplantation.Signal Transduct Target Ther. 2023 Mar 11;8(1):110. doi: 10.1038/s41392-023-01377-9. Signal Transduct Target Ther. 2023. PMID: 36906586 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
